An Evaluation of Integration Success and Maintenance of Short Implants in Maxillas Needing Sinus Augmentation

NCT ID: NCT00725049

Last Updated: 2024-02-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective randomized study will evaluate the integration success while supporting a prosthesis for short implants placed into maxillary sites having minimal bone height that would otherwise need sinus augmentation. The resources utilized during treatment will be assessed.

Study (null) hypothesis: the overall benefit of using short length implants to avoid sinus augmentation procedures will offset differences in the cumulative implant survival rates observed between treatment groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this randomized study, patients needing restorations in the posterior maxilla will be randomly assigned to the short implant group (test) or the standard length and augmentation group (control). All implants will be placed using a two-stage approach with healing abutments placed at three months and temporary prosthesis at four months following implant and/ or sinus augmentation surgery. Time, materials, and efforts associated with treating test and control cases will be documented to allow an assessment of the costs incurred with each approach.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tooth Disease Partial Edentulism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dental implant (Nanotite)

Dental implants of short length placed without sinus lifts

Group Type ACTIVE_COMPARATOR

Dental Implant (Nanotite)

Intervention Type DEVICE

Root form titanium dental implant

Control group

Dental implants of standard length placed simultaneously with sinus augmentation

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dental Implant (Nanotite)

Root form titanium dental implant

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Nanotite

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients of either sex and any race greater than 18 years of age
* patients with partial edentulism in the posterior maxilla requiring a unilateral implant-supported maxillary prosthesis
* patients with a residual alveolar floor of the sinus between 4 and 6 mm in height, as assessed on intraoral radiographs, and able to receive at least a 4mm wide implant
* patients must be physically able to tolerate conventional surgical and restorative procedures

Exclusion Criteria

* patients with active infection or severe inflammation in the areas intended for implant placement
* patients with a \> 10 cigarettes per day smoking habit
* patients with uncontrolled diabetes or metabolic bone disease
* patient with a history of therapeutic radiation to the head
* patients who are known to be pregnant
* patients with para-functional habits with evidence of severe bruxing or clenching
* patients not able to commit to a 3 year follow-up program
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ZimVie

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mariano A Sanz, MD, DDS

Role: PRINCIPAL_INVESTIGATOR

Universidad Complutense de Madrid

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidad Complutense de Madrid

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2611

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.